St. Jude Medical, Inc. has announced the first implant of its Portico™ transcatheter aortic valve implant (TAVI) in a European clinical trial to support CE Mark approval.
Clinical/Educational
90% Of Retrievable IVC Filters Not Retrieved According To Boston Researchers
Boston researchers have found that less than 10% of retrievable IVC filters were removed from patients, despite the fact that the indication for the filter placement was no longer present at discharge.
Dialysis At Home: Baxter To Fund Two Research Studies
Baxter Healthcare is providing over £200,000 of funding to two UK studies with the goal of establishing an improved evidence base for home dialysis treatment.
Abbott Trials Absorb™ Bioresorbable Vascular Scaffold Against Metallic Drug Eluting Stent
Abbott today announced the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial to evaluate the safety, efficacy and performance of the Absorb™ bioresorbable vascular scaffold (BVS) compared to the company’s XIENCE PRIME™ Everolimus Eluting Coronary Stent System.
Are You Carrying Your Pacemaker Donor Card?
Reusing Pacemakers from deceased donors is safe and effective, study finds.
“Meerkats And Avatars” Cambridge (UK) Technology Event
Cambridge Technology Showcase: Reducing incidence of falls in the elderly, bringing cheap diagnosis of killer diseases, aid for physios with sophisticated gait analysis, coatings for medical devices to reduce biofilms.
AtriCure Aiming At Thoracoscopic Indication For AtriClip LAA Occlusion Device
MedCity News has reported on AtriCure’s quest to gain approval for use of the device in a minimally invasive fashion in stand-alone procedures to close the LAA.
US Radiological Society Meeting Last Week
The Radiological Society of North America held its 97th Scientific Assembly and Annual Meeting in Chicago from Sunday, November 27 – Friday, December 2.
UK Government Proposes Using NHS Data To Fuel Technology Innovation
UK Prime Minister David Cameron has unveiled proposals under which patient data could be sold to the private sector in order to be used in the quest for better and more accurately targeted medical technologies.
Tissue Regenix’s University Partner wins Queen’s Anniversary Prize
Tissue Regenix’s University Partner (The Institute of Medical and Biological Engineering at Leeds University) has been awarded Queen’s Anniversary Prize, the highest accolade for an academic institution.
First Patient In The Svelte DIRECT Drug-Eluting Stent Study
SvelteMedical Systems Announces Treatment of First Patient in the DIRECT Drug-Eluting Stent Study.
Innovations in Cardiovascular Interventions 2011, Tel Aviv, December
The “Innovations in Cardiovascular Interventions (ICI) – From Idea to Reality” meeting will be held on December 4-6, 2011 in Tel-Aviv, Israel.
Multidisciplinary European Endovascular Therapy Congress In Rome Next Month
The tenth running of the Multidisciplinary European Endovascular Therapy (MEET) congress will be held in Rome on December 1st-3rd, at the Crowne Plaza St Peters Hotel.
BIOTRONIK Announces Six-Month Coronary Stenting ENERGY Registry Results
Biotronik’s thin strut PRO-Kinetic Energy bare metal stent with passive PROBIO coating showed excellent results in a 1,000 patient all-comers registry.
Boston’s WATCHMAN® Device First Patients in Latin America
Boston Scientific’s Innovative Watchman left atrial appendage closure device, a proven alternative to anticoagulant drugs for patients in atrial fibrillation at high risk for stroke, has been implanted for the first time in Latin America.
Stent Shrinkage Still In Spotlight. FDA Wades In.
FDA is taking a proactive stance and working with manufacturers to understand the issue of longitudinal compression in next generation Drug-Eluting Stents.